A notable exception is Prostate cancer antigen 3 (PCA3) in the urine of prostate cancer patients which has been intensively investigated and is potentially more specific than Prostate-specific antigen (PSA) levels (reviewed in 97). The gene discussed is PCA3; the disease is prostate carcinoma.